Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions...

65
Topic 1 Organic Structures and Interactions of Drugs

Transcript of Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions...

Page 1: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Topic 1 Organic Structuresand Interactions of Drugs

Page 2: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 3: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 4: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 5: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 6: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 7: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 8: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 9: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 10: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 11: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 12: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 13: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 14: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 15: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 16: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 17: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 18: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 19: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 20: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 21: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 22: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 23: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 24: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 25: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 26: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 27: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 28: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 29: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 30: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 31: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 32: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 33: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 34: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 35: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 36: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of
Page 37: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Drug Targeting PrinciplesChapter 2-Patrick

Page 38: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

LipidsLipidsCell membrane lipidsCell membrane lipids

ProteinsProteinsReceptorsReceptorsEnzymesEnzymesCarrier proteinsCarrier proteinsStructural proteins (Structural proteins (tubulintubulin))

Nucleic acidsNucleic acidsDNADNARNARNA

CarbohydratesCarbohydratesCell surface carbohydratesCell surface carbohydratesAntigens and recognition moleculesAntigens and recognition molecules

Drug targetsDrug targets

Page 39: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Cell StructureCell Structure•• Human, animal and plant cells are eukaryotic cellsHuman, animal and plant cells are eukaryotic cells

•• The nucleus contains the genetic blueprint for life (DNA)The nucleus contains the genetic blueprint for life (DNA)

•• The fluid contents of the cell are known as the cytoplasmThe fluid contents of the cell are known as the cytoplasm

•• Structures within the cell are known as organellesStructures within the cell are known as organelles

•• Mitochondria are the source of energy productionMitochondria are the source of energy production

•• Ribosomes Ribosomes are the cellare the cell’’s protein s protein ‘‘factoriesfactories’’

•• Rough endoplasmic reticulum is the location for protein synthesisRough endoplasmic reticulum is the location for protein synthesis

Page 40: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

PhospholipidBilayer

ExteriorHigh [Na+]

InteriorHigh [K+]

Cell MembraneCell Membrane

Proteins

Page 41: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

PolarHeadGroup

Hydrophobic Tails

Cell MembraneCell Membrane

PolarHeadGroup

Hydrophobic Tails

CHCH2 CH2O O

O

P OOOCH2CH2NMe3

O O

Page 42: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Cell MembraneCell Membrane

•• The cell membrane is made up of a The cell membrane is made up of a phospholipid bilayerphospholipid bilayer

•• The hydrophobic tails interact with each other by van The hydrophobic tails interact with each other by van derderWaals Waals interactions and are hidden from the aqueous mediainteractions and are hidden from the aqueous media

•• The polar head groups interact with water at the inner andThe polar head groups interact with water at the inner andouter surfaces of the membraneouter surfaces of the membrane

•• The cell membrane provides a hydrophobic barrier aroundThe cell membrane provides a hydrophobic barrier aroundthe cell, preventing the passage of water and polar moleculesthe cell, preventing the passage of water and polar molecules

•• Proteins are present, floating in the cell membraneProteins are present, floating in the cell membrane

•• Some act as ion channels and carrier proteinsSome act as ion channels and carrier proteins

Page 43: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Drug targetsDrug targets

•• Drug targets are large molecules - macromoleculesDrug targets are large molecules - macromolecules•• Drugs are generally much smaller than their targetsDrugs are generally much smaller than their targets•• Drugs interact with their targets by binding to binding sitesDrugs interact with their targets by binding to binding sites•• Binding sites are typically hydrophobic pockets on the surfaceBinding sites are typically hydrophobic pockets on the surface

of macromoleculesof macromolecules•• Binding interactions typically involve intermolecular bondsBinding interactions typically involve intermolecular bonds•• Most drugs are in equilibrium between being bound andMost drugs are in equilibrium between being bound and

unbound to their targetunbound to their target•• Functional groups on the drug are involved in bindingFunctional groups on the drug are involved in binding

interactions and are called binding groupsinteractions and are called binding groups•• Specific regions within the binding site that are involved inSpecific regions within the binding site that are involved in

binding interactions are called binding regionsbinding interactions are called binding regions

Page 44: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Macromolecular target

Drug

Unbound drug

Macromolecular target

Drug

Bound drug

Bindingsite

Drug

Binding site

Binding regions

Binding groups

Intermolecular bonds

Drug targetsDrug targets

Page 45: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Drug targetsDrug targets

•• Binding interactions usually result in an induced fit where theBinding interactions usually result in an induced fit where the

binding site changes shape to accommodate the drugbinding site changes shape to accommodate the drug

•• The induced fit may also alter the overall shape of the drugThe induced fit may also alter the overall shape of the drug

targettarget

•• Important to the pharmacological effect of the drugImportant to the pharmacological effect of the drug

Page 46: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesElectrostatic or ionic bondElectrostatic or ionic bond•• Strongest of the intermolecular bonds (20-40 kJ molStrongest of the intermolecular bonds (20-40 kJ mol-1-1))•• Takes place between groups of opposite chargeTakes place between groups of opposite charge•• The strength of the ionic interaction is inversely proportionalThe strength of the ionic interaction is inversely proportional

to the distance between the two charged groupsto the distance between the two charged groups•• Stronger interactions occur in hydrophobic environmentsStronger interactions occur in hydrophobic environments•• The strength of interaction drops off less rapidly withThe strength of interaction drops off less rapidly with

distance than with other forms of intermolecular interactionsdistance than with other forms of intermolecular interactions•• Ionic bonds are the most important initial interactions as aIonic bonds are the most important initial interactions as a

drug enters the binding sitedrug enters the binding site

Drug

O

O H3N Target

Drug NH3Target

O

O

Page 47: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forces

Electrostatic or ionic bondElectrostatic or ionic bond

Electrostatic interactions: governed by Coulomb’s lawWhere V is the interaction energy between two charges in kJ/mol

• q1 and q2 are charges in multiples of the protoniccharge

• e is the dielectric constant of the medium(a measureof polarity)

• r is distance in �Å (10-10 M)

V =1390q

1q2

!r

Page 48: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesHydrogen bondsHydrogen bonds

X H

Drug

Y Target

Drug XTarget

HY!+

!+!- !-

!-!-

HBD HBA HBA HBD

•• Vary in strengthVary in strength•• Weaker than electrostatic interactions but stronger than vanWeaker than electrostatic interactions but stronger than van

der Waals der Waals interactionsinteractions•• A hydrogen bond takes place between an electron deficientA hydrogen bond takes place between an electron deficient

hydrogen and an electron rich heteroatom (N or O)hydrogen and an electron rich heteroatom (N or O)•• The electron deficient hydrogen is usually attached to aThe electron deficient hydrogen is usually attached to a

heteroatom (O or N)heteroatom (O or N)•• The electron deficient hydrogen is called a hydrogen bondThe electron deficient hydrogen is called a hydrogen bond

donordonor•• The electron rich heteroatom is called a hydrogen bondThe electron rich heteroatom is called a hydrogen bond

acceptoracceptor

Page 49: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesHydrogen bondsHydrogen bonds

Page 50: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesHydrogen bondsHydrogen bonds

YX H YX H

Hybridisedorbital

Hybridisedorbital

1sorbital

HBAHBAHBDHBD

•• The interaction involves The interaction involves orbitals orbitals and is directionaland is directional

•• Optimum orientation is where the X-H bond points directlyOptimum orientation is where the X-H bond points directlyto the lone pair on Y such that the angle between X, H and Yto the lone pair on Y such that the angle between X, H and Yis 180is 180oo

Page 51: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesHydrogen bondsHydrogen bonds

•• Examples of strong hydrogen bond acceptorsExamples of strong hydrogen bond acceptors- - carboxylate carboxylate ion, phosphate ion, tertiary amineion, phosphate ion, tertiary amine

•• Examples of moderate hydrogen bond acceptorsExamples of moderate hydrogen bond acceptors- carboxylic acid, amide oxygen, - carboxylic acid, amide oxygen, ketoneketone, ester, ether, alcohol, ester, ether, alcohol

•• Examples of poor hydrogen bond acceptorsExamples of poor hydrogen bond acceptors- - sulfursulfur, fluorine, chlorine, aromatic ring, amide nitrogen,, fluorine, chlorine, aromatic ring, amide nitrogen,

aromatic aminearomatic amine

•• Example of good hydrogen bond donorsExample of good hydrogen bond donors- Quaternary ammonium ion- Quaternary ammonium ion

Page 52: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesHydrogen bonds-The importance of hydrogen bonds, e.g.Hydrogen bonds-The importance of hydrogen bonds, e.g.

Page 53: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesVan Van der Waals der Waals interactionsinteractions

Binding site

DRUG

δ- δ+

•• Very weak interactions (2-4 kJmolVery weak interactions (2-4 kJmol-1-1,,~~4 kJ/Å4 kJ/Å2 2 contactcontact))•• Occur between hydrophobic(and other) regions of the drug and theOccur between hydrophobic(and other) regions of the drug and the

targettarget•• Due to transient areas of high and low electron densities leading toDue to transient areas of high and low electron densities leading to

temporary dipolestemporary dipoles•• Interactions drop off rapidly with distanceInteractions drop off rapidly with distance•• Drug must be close to the binding region for interactions to occurDrug must be close to the binding region for interactions to occur•• The overall contribution of van The overall contribution of van der Waals der Waals interactions can beinteractions can be

crucial to bindingcrucial to binding

δ+ δ-

Hydrophobic regions

Transient dipole on drugδ+ δ-

van der Waals interaction

Page 54: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesDipole-dipole interactionsDipole-dipole interactions

• Can occur if the drug and the binding site have dipole moments• Dipoles align with each other as the drug enters the binding site• Dipole alignment orientates the molecule in the binding site• Orientation is beneficial if other binding groups are positioned

correctly with respect to the corresponding binding regions• Orientation is detrimental if the binding groups are not positioned

correctly with respect to corresponding binding regions• The strength of the interaction decreases with distance more

quickly than with electrostatic interactions, but less quickly thanwith van der Waals interactions

Page 55: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Binding site

Localiseddipole moment

Dipole moment

RC

R

O

δ+

δ−

Binding site

R

CR O

Dipole-dipole interactionsDipole-dipole interactionsIntermolecular bonding forcesIntermolecular bonding forces

Page 56: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesIon-dipole interactionsIon-dipole interactions

• Occur where the charge on one molecule interacts with the dipolemoment of another

• Stronger than a dipole-dipole interaction

• Strength of interaction falls off less rapidly with distance than fora dipole-dipole interaction

C

O

O

Binding siteBinding site

δ+δ+

δ−δ−

RR

CCRR OO

H3N

Binding siteBinding site

δ+δ+

δ−δ−

RR

CCRR OO

Page 57: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Intermolecular bonding forcesIntermolecular bonding forcesInduced dipole interactionsInduced dipole interactions

• Occur where the charge on one molecule induces a dipole onanother

• Occurs between a quaternary ammonium ion and an aromaticring

Binding siteBinding site

RR NN RR33

++δ−δ−

δ+δ+

Page 58: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

RC

R

O

OH

HH H

O

H

H

O

H

H

O

OH

Binding siteDesolvation - Energy penalty Binding - Energy gain

OH

RC

R

O

Binding site

RC

R

O

OH

Binding site

Desolvation Desolvation penaltiespenalties• Polar regions of a drug and its target are solvated prior to

interaction

• Desolvation is necessary and requires energy• The energy gained by drug-target interactions must be greater

than the energy required for desolvation

Page 59: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Unstructured waterUnstructured waterIncrease in entropyIncrease in entropy

DrugDrugDRUGDRUG

Structured water layer Structured water layer round hydrophobic regionsround hydrophobic regions

HydrophobicHydrophobic regions regionsWaterWater

Binding siteBinding site Binding siteBinding site

DrugDrugDRUGDRUG

BindingBinding

Hydrophobic interactions Hydrophobic interactions• Hydrophobic regions of a drug and its target are not solvated• Water molecules interact with each other and form an ordered

layer next to hydrophobic regions - negative entropy• Interactions between the hydrophobic interactions of a drug and

its target ‘free up’ the ordered water molecules• Results in an increase in entropy• Beneficial to binding energy

Page 60: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Hydrophobic interactionsHydrophobic interactions• A nonpolar solute "organizes" water • The H-bond network of water reorganizes to accommodate the

nonpolar solute • T his is an increase in "order" of water-This is a decrease in

ENTROPY

Transfer reaction (25˚C) H kcal/mol

S cal/K mol

G kcal/mol

CH4 in benzene→ CH4 in wate r -2.8 -18 +2.6 CH4 in ether→ CH4 in water -2.4 -19 +3.3 CH4 in CCl4→ CH4 in water -2.5 -18 +2.9 C3H8 liquid→ C3H8 in water -1.8 -23 +5.1 Recall G= H-T S

Page 61: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Hydrophobic regionHydrophobic region

Drugs acting on cell membrane lipids - Anaesthetics and some antibiotics

Action of amphotericin B (antifungal agent) - builds tunnels/defects through membrane and drains cell

Drug Targets - Cell Membrane LipidsDrug Targets - Cell Membrane Lipids

HydrophilicHydrophilicHydrophilicHydrophilic

HydrophilicHydrophilic

OOH

HO

OH

HOOC

OH

O

Me

OH

OH

Me

OH O OH

Me

O

O

HONH2

HO

Me

H

Page 62: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Polar tunnel formedPolar tunnel formedEscape route for ionsEscape route for ions

CELL

MEMBRANE

TUNNEL

HO

HO

HO

HO

HO

HO

HO

HO2C CO2H

Sugar

OH OH

Sugar

HO

HO

HO

HO

HO

HO

HO

OH

OH

OH

OH

OH

OH

OH

Sugar

OH OH

Sugar

HO2C CO2H

OH

OH

OH

OH

OH

OH

OH

Drug Targets - Cell Membrane LipidsDrug Targets - Cell Membrane Lipids

Probably not correct model, but correct concept

Page 63: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Drug Targets - CarbohydratesDrug Targets - Carbohydrates• Carbohydrates play important roles in cell recognition, regulation

and growth• Potential targets for the treatment of bacterial and viral infection,

cancer and autoimmune disease• Carbohydrates act as antigens

Carbohydrate 'tag'

CellCellmembranemembrane

Page 64: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Drug Targets - CarbohydratesDrug Targets - Carbohydrates

Ceramide 'anchor'Carbohydrate 'tag'

O

OHO

O

OH

HO

OH

(CH2)12CH3

HN (CH2)16CH3

O

Ceramide unit

SUGARS

Carbohydrates

OH

(CH2)12CH3HO

NH2

Sphingosine

HO (CH2)16CH3

O

Fatty Acid (e.g. Stearic acid)O

OHHO

RO

OH

HO

Carbohydrate (R=various carbohydrate structures)

Page 65: Topic 1 Organic Structures and Interactions of Drugs · DRUG δ- δ+ • Very weak interactions (2-4 kJmol-1,,~4 kJ/Å2 contact) • Occur between hydrophobic(and other) regions of

Drug Targets - Proteins and Nucleic acids up later!Drug Targets - Proteins and Nucleic acids up later!